secwatch / observer
8-K filed January 2, 2026, 6:59 PM ET ticker RNXT CIK 0001574094
regulatory confidence high sentiment negative materiality 0.70

RenovoRx, Inc. (RNXT): Nasdaq/NYSE listing notice — RenovoRx receives Nasdaq deficiency notice for minimum bid price non-compliance

RenovoRx, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

RenovoRx, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2), 5810(c)(3)(A)
Exact text from the filing
December 31, 2025, RenovoRx, Inc., a Delaware corporation (the “Company”) received a deficiency notice from The Nasdaq Stock Market (“Nasdaq”) informing the Company that its common stock, par value $0.0001 per share (the “Common Stock”), failed to comply with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 32 consecutive business days prior to the date of the notice from Nasdaq. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on Th
View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

RenovoRx, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-26-000113
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.